SVEP1 and intrahepatic cholangiocarcinoma: Subsequently, the clinical analysis indicated that the decreased expression of SVEP1 in tumor tissues was an independent risk factor for the prognosis of ICC (DFS, p = .017; OS, p = .040) (Table 1).